ArticleJournal of obstetrics and gynaecology of India2019
Post-reproductive Health: Window of Opportunity for Preventing Comorbidities.
Article in Journal of obstetrics and gynaecology of India, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Article
- Oral Mycobiome Alterations in Postmenopausal Women: Links to Inflammation, Xerostomia, and Systemic Health.Biomedicines · 2024Review
- Modulation of neural gene networks by estradiol in old rhesus macaque females.bioRxiv : the preprint server for biology · 2023Article
- Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis.Frontiers in aging · 2023Article
- Why menopause matters in the academic workplace.Nature · 2022Article
- Effects of estradiol supplementation on the brain transcriptome of old rhesus macaques maintained on an obesogenic diet.GeroScience · 2022Article
- Musculoskeletal Disorders and Menopause.Journal of obstetrics and gynaecology of India · 2019Article
- Evaluating the Quality of Life among Menopausal Women in the Urban Field Practice Area of a Medical College in Guntur.Journal of mid-life healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-reproductive health is a challenging issue as it is surrounded by many controversies. Menopausal hormone therapy (MHT) has witnessed a rise and fall over last several years. We do understand that comorbidities incidence rises beyond menopause and we need to prevent them. When MHT was used universally, the risk-benefit ratio became unfavorable. Hence, the use of MHT dropped drastically. But newer studies have introduced the concept of window of opportunity, wherein MHT does not have harmful effects, but in fact it will prevent comorbidities associated with menopause. This editorial focuses on the prevention of menopause- and MHT-related comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.